• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SCPMG Becomes Quintiles’ Fourth Prime Site

SCPMG Becomes Quintiles’ Fourth Prime Site

May 26, 2010
CenterWatch Staff

Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) has just been welcomed into Quintiles’ Global Prime Sites group, becoming one of only four clinical research groups worldwide to make the cut since the program started in 2007.

The prime sites are essentially very large, high-performing, usually hospital-based research groups with which Quintiles has worked for years and desires a closer, more alliance-like relationship. For SCPMG, this means Quintiles will now provide access to all of its larger studies before offering them to other sites. It also means SCPMG gets funding from Quintiles to dedicate a full-time employee to managing the new relationship between the two entities.

“I think it’s going to be really good for the both of us,” said Donald Fong, director of clinical trials for SCPMG’s Department of Research & Evaluation. “Quintiles is the largest CRO, so this will allow access to so many more trials for our members.”

Adam Chasse, senior director of Quintiles’ Prime Sites program, said the goal is to have SCPMG working on about 20 Quintiles studies in the first year of the new partnership. That’s quite a ramp up when one considers that, in the past 10 years, Quintiles and SCPMG have worked on 30 studies together.

In return, Quintiles gets access to a healthcare group with 6,000 physicians, several hundred principal investigators across 13 hospitals from San Diego to Bakersfield, and the 3.2 million Southern California residents in Kaiser’s health plan.

The doctors of SCPMG have been conducting clinical research for many years, Fong said, but the center just developed a formal clinical research group in 2004 to streamline regulatory issues and better handle coordination of studies. SCPMG now juggles about 400 trials per year.

SCPMG’s principal investigators work in about 40 therapeutic areas, but key ones include oncology, cardiology, allergy, infectious diseases and HIV, said Fong. The center hopes to expand further into neurology and psychiatry.

When Quintiles launched its Global Prime Sites group three years ago, Queen Mary College (the medical school at the University of London) became the first member. Next, in 2008, came Washington Hospital Center in Washington, D.C. Last year, Quintiles asked the University of Pretoria in South Africa to come aboard.

With the Prime Sites program, said Chasse, Quintiles is attempting to sign up large, high-recruiting sites that can accommodate studies best done in an inpatient setting, and in the most pressing therapeutic areas.

The program has grown by one site per year, but that’s about to accelerate on a global scale. Chasse said Quintiles will be adding more than just SCPMG in 2010.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing